vs
CALERES INC（CAL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
CALERES INC的季度营收约是Royalty Pharma plc的1.3倍（$790.1M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 0.3%，领先34.1%），CALERES INC同比增速更快（6.6% vs 4.8%），过去两年CALERES INC的营收复合增速更高（6.5% vs 4.6%）
Caleres Inc是一家美国鞋履企业，旗下拥有并运营多个鞋履品牌，总部坐落于圣路易斯郊区密苏里州克莱顿。该企业前身是1878年在圣路易斯成立的Bryan, Brown & Company，此后历经多次更名，其前身汉密尔顿-布朗鞋业在20世纪初曾是美国最大的鞋履制造商。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CAL vs RPRX — 直观对比
营收规模更大
CAL
是对方的1.3倍
$622.0M
营收增速更快
CAL
高出1.9%
4.8%
净利率更高
RPRX
高出34.1%
0.3%
两年增速更快
CAL
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $790.1M | $622.0M |
| 净利润 | $2.4M | $214.2M |
| 毛利率 | 41.8% | — |
| 营业利润率 | 1.5% | 62.4% |
| 净利率 | 0.3% | 34.4% |
| 营收同比 | 6.6% | 4.8% |
| 净利润同比 | -94.2% | 2.9% |
| 每股收益（稀释后） | $0.07 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CALRPRX
| Q4 25 | $790.1M | $622.0M | ||
| Q3 25 | $658.5M | $609.3M | ||
| Q2 25 | $614.2M | $578.7M | ||
| Q1 25 | $639.2M | $568.2M | ||
| Q4 24 | $740.9M | $593.6M | ||
| Q3 24 | $683.3M | $564.7M | ||
| Q2 24 | $659.2M | $537.3M | ||
| Q1 24 | $697.1M | $568.0M |
净利润CALRPRX
| Q4 25 | $2.4M | $214.2M | ||
| Q3 25 | $6.7M | $288.2M | ||
| Q2 25 | $6.9M | $30.2M | ||
| Q1 25 | $4.9M | $238.3M | ||
| Q4 24 | $41.4M | $208.2M | ||
| Q3 24 | $30.0M | $544.0M | ||
| Q2 24 | $30.9M | $102.0M | ||
| Q1 24 | $55.7M | $4.8M |
毛利率CALRPRX
| Q4 25 | 41.8% | — | ||
| Q3 25 | 43.4% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 43.0% | — | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 46.9% | — | ||
| Q1 24 | 43.9% | — |
营业利润率CALRPRX
| Q4 25 | 1.5% | 62.4% | ||
| Q3 25 | 1.4% | 70.1% | ||
| Q2 25 | 1.9% | 36.3% | ||
| Q1 25 | 1.2% | 94.0% | ||
| Q4 24 | 7.7% | 60.9% | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 6.5% | 50.2% | ||
| Q1 24 | 4.4% | -13.0% |
净利率CALRPRX
| Q4 25 | 0.3% | 34.4% | ||
| Q3 25 | 1.0% | 47.3% | ||
| Q2 25 | 1.1% | 5.2% | ||
| Q1 25 | 0.8% | 41.9% | ||
| Q4 24 | 5.6% | 35.1% | ||
| Q3 24 | 4.4% | 96.3% | ||
| Q2 24 | 4.7% | 19.0% | ||
| Q1 24 | 8.0% | 0.8% |
每股收益（稀释后）CALRPRX
| Q4 25 | $0.07 | $0.49 | ||
| Q3 25 | $0.20 | $0.67 | ||
| Q2 25 | $0.21 | $0.07 | ||
| Q1 25 | $0.17 | $0.55 | ||
| Q4 24 | $1.19 | $0.46 | ||
| Q3 24 | $0.85 | $1.21 | ||
| Q2 24 | $0.88 | $0.23 | ||
| Q1 24 | $1.56 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $616.8M | $9.7B |
| 总资产 | $2.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CALRPRX
| Q4 25 | $34.0M | $618.7M | ||
| Q3 25 | $191.5M | $938.9M | ||
| Q2 25 | $33.1M | $631.9M | ||
| Q1 25 | $29.6M | $1.1B | ||
| Q4 24 | $33.7M | $929.0M | ||
| Q3 24 | $51.8M | $950.1M | ||
| Q2 24 | $30.7M | $1.8B | ||
| Q1 24 | $21.4M | $843.0M |
总债务CALRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CALRPRX
| Q4 25 | $616.8M | $9.7B | ||
| Q3 25 | $613.3M | $9.6B | ||
| Q2 25 | $605.2M | $9.5B | ||
| Q1 25 | $599.0M | $9.8B | ||
| Q4 24 | $598.3M | $10.3B | ||
| Q3 24 | $606.1M | $10.3B | ||
| Q2 24 | $570.3M | $9.8B | ||
| Q1 24 | $560.6M | $9.9B |
总资产CALRPRX
| Q4 25 | $2.1B | $19.6B | ||
| Q3 25 | $2.2B | $19.3B | ||
| Q2 25 | $1.9B | $18.3B | ||
| Q1 25 | $1.9B | $17.6B | ||
| Q4 24 | $2.0B | $18.2B | ||
| Q3 24 | $2.0B | $18.0B | ||
| Q2 24 | $1.9B | $17.7B | ||
| Q1 24 | $1.8B | $16.1B |
负债/权益比CALRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-12.4M | — |
| 自由现金流率自由现金流/营收 | -1.6% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | -0.50× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $14.4M | — |
8季度趋势，按日历期对齐
经营现金流CALRPRX
| Q4 25 | $-1.2M | $827.1M | ||
| Q3 25 | $47.3M | $702.6M | ||
| Q2 25 | $-5.7M | $364.0M | ||
| Q1 25 | $28.7M | $596.1M | ||
| Q4 24 | $-39.8M | $742.5M | ||
| Q3 24 | $79.6M | $703.6M | ||
| Q2 24 | $36.1M | $658.2M | ||
| Q1 24 | $43.0M | $664.6M |
自由现金流CALRPRX
| Q4 25 | $-12.4M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $-26.2M | — | ||
| Q1 25 | $18.0M | — | ||
| Q4 24 | $-57.4M | — | ||
| Q3 24 | $68.5M | — | ||
| Q2 24 | $26.3M | — | ||
| Q1 24 | $32.4M | — |
自由现金流率CALRPRX
| Q4 25 | -1.6% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | -4.3% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 4.6% | — |
资本支出强度CALRPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.5% | — |
现金转化率CALRPRX
| Q4 25 | -0.50× | 3.86× | ||
| Q3 25 | 7.05× | 2.44× | ||
| Q2 25 | -0.81× | 12.06× | ||
| Q1 25 | 5.82× | 2.50× | ||
| Q4 24 | -0.96× | 3.57× | ||
| Q3 24 | 2.66× | 1.29× | ||
| Q2 24 | 1.17× | 6.45× | ||
| Q1 24 | 0.77× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
